These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22748271)

  • 1. Clinical trial design in head and neck cancer: what has the oncologist learned?
    Adelstein DJ
    Lancet Oncol; 2012 Jul; 13(7):e318-23. PubMed ID: 22748271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design issues in head and neck clinical trials: a statistician's perspective.
    Fortpied C; Liberatoscioli C; Bogaerts J
    Anticancer Drugs; 2011 Aug; 22(7):682-7. PubMed ID: 21709617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and performance of clinical trials in head and neck cancer.
    Awada A; Lacombe D; Liberatoscioli C
    Curr Opin Oncol; 2010 May; 22(3):184-5. PubMed ID: 20150810
    [No Abstract]   [Full Text] [Related]  

  • 4. New options in the treatment of locally advanced head and neck cancer: role for induction chemotherapy.
    Cruz JJ; Ocaña A; Navarro M; Barco ED; Fonseca E
    Cancer Treat Rev; 2008 May; 34(3):268-74. PubMed ID: 18194842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of clinical trials in head and neck cancer.
    Yang ES; Murphy BM; Chung CH; Netterville JL; Burkey BB; Gilbert J; Yarbrough WG; Sinard R; Cmelak AJ
    Crit Rev Oncol Hematol; 2009 Jul; 71(1):29-42. PubMed ID: 18996026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial design limitations in head and neck squamous cell carcinomas.
    Yun HJ; Bogaerts J; Awada A; Lacombe D
    Curr Opin Oncol; 2007 May; 19(3):210-5. PubMed ID: 17414638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidisciplinary care of the patient with head and neck cancer.
    Saloura V; Langerman A; Rudra S; Chin R; Cohen EE
    Surg Oncol Clin N Am; 2013 Apr; 22(2):179-215. PubMed ID: 23453331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ preservation in multimodality therapy of head and neck cancer.
    Urba S; Wolf GT
    Hematol Oncol Clin North Am; 1991 Aug; 5(4):713-24. PubMed ID: 1890062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data.
    Michiels S; Le Maître A; Buyse M; Burzykowski T; Maillard E; Bogaerts J; Vermorken JB; Budach W; Pajak TF; Ang KK; Bourhis J; Pignon JP;
    Lancet Oncol; 2009 Apr; 10(4):341-50. PubMed ID: 19246242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of chemotherapy in the curative treatment of locally advanced head and neck cancer.
    Haddad RI; Wirth L; Posner MR
    Expert Rev Anticancer Ther; 2003 Jun; 3(3):331-8. PubMed ID: 12820776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of clinical trials in head and neck cancer 2014.
    Liu JC; Ridge JA; Brizel DM; O'Sullivan B; Cohen EW; Mann BS; Adelstein DJ
    Otolaryngol Head Neck Surg; 2015 Mar; 152(3):410-7. PubMed ID: 25605695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of HPV-related head and neck cancer in clinical trials: opportunity to translate scientific insight into personalized care.
    Chung CH; Schwartz DL
    Otolaryngol Clin North Am; 2012 Aug; 45(4):795-806. PubMed ID: 22793853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the results of meta-analyses in the treatment of head and neck squamous cell cancer.
    Hotte SJ; Wright JR
    Hematol Oncol Clin North Am; 2008 Dec; 22(6):1257-66, x. PubMed ID: 19010272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current status of clinical trials on pre- and postoperative chemotherapy for head and neck cancer].
    Inuyama Y; Fukuda S; Horiuchi M
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():338-47. PubMed ID: 7986113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted therapies in squamous cell carcinoma of the head and neck.
    Gold KA; Lee HY; Kim ES
    Cancer; 2009 Mar; 115(5):922-35. PubMed ID: 19156911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding role of the medical oncologist in the management of head and neck cancer.
    Choong N; Vokes E
    CA Cancer J Clin; 2008; 58(1):32-53. PubMed ID: 18096865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New perspectives in medical approach to therapy of head and neck squamous cell carcinoma.
    Santarelli A; Lo Russo L; Bambini F; Campisi G; Lo Muzio L
    Minerva Stomatol; 2009 Sep; 58(9):445-52. PubMed ID: 19893469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reporting of time-to-event end points and tracking of failures in randomized trials of radiotherapy with or without any concomitant anticancer agent for locally advanced head and neck cancer.
    Le Tourneau C; Michiels S; Gan HK; Siu LL
    J Clin Oncol; 2009 Dec; 27(35):5965-71. PubMed ID: 19805677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative clinical studies for head and neck cancer in Japan].
    Fujii M
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1502-8. PubMed ID: 12355935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neo-adjuvant chemotherapy in patients with head and neck cancer].
    Tsukuda M
    Gan To Kagaku Ryoho; 1995 Nov; 22(13):1905-11. PubMed ID: 7487119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.